Krystal Biotech, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	116.4M	107.1M	97.8M	96.0M	88.2M	91.1M	83.8M	70.3M
Cost of Goods Sold	6.3M	10.9M	5.7M	7.2M	5.0M	4.9M	6.7M	6.0M
Gross Profit	110.0M	96.2M	92.1M	88.9M	83.2M	86.2M	77.2M	64.3M
R&D Expenses	15.3M	16.2M	13.2M	14.4M	14.3M	13.5M	13.5M	15.6M
Operating Expenses	56.3M	51.8M	50.8M	49.6M	47.0M	44.8M	54.7M	55.7M
Operating Income	53.7M	44.4M	41.4M	39.3M	36.2M	41.4M	22.4M	8.6M
Other Income / Gains	7.8M	6.7M	6.6M	7.5M	7.4M	7.2M	7.3M	7.5M
Net Income	55.9M	51.4M	79.4M	38.3M	35.7M	45.5M	27.2M	15.6M
EPS (Diluted)	1.91	1.77	2.74	1.33	1.24	1.58	0.95	0.54
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.946	0.898	0.942	0.925	0.943	0.946	0.92	0.915
General And Administrative Expenses	41.0M	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0	0
Selling General And Administrative Expenses	41.0M	41.3M	37.6M	35.2M	32.7M	31.3M	28.7M	27.6M
Other Expenses	0	-5.7M	0	0	0	0	12.5M	12.5M
Cost And Expenses	62.7M	62.7M	56.4M	56.7M	52.0M	49.8M	61.4M	61.7M
Interest Income	0	-14.1M	6.6M	7.5M	0	0	0	7.5M
Interest Expense	0	0	0	0	0	0	0	0
Depreciation And Amortization	1.7M	1.8M	1.6M	1.5M	1.6M	1.6M	1.5M	2.0M
Ebitda	55.4M	39.6M	49.6M	40.9M	37.8M	42.9M	36.5M	23.1M
Ebitdaratio	0.476	0.37	0.507	0.425	0.429	0.471	0.435	0.328
Operating Income Ratio	0.461	0.415	0.423	0.409	0.41	0.454	0.268	0.122
Income Before Tax	61.4M	51.1M	48.0M	46.8M	43.6M	48.6M	29.8M	16.0M
Income Before Tax Ratio	0.528	0.477	0.49	0.487	0.494	0.533	0.355	0.228
Income Tax Expense	5.5M	-268K	-31.4M	8.4M	7.9M	3.1M	2.6M	477K
Net Income Ratio	0.481	0.48	0.812	0.399	0.405	0.499	0.324	0.222
Epsdiluted	1.83	1.70	2.66	1.29	1.20	1.52	0.91	0.53
Weighted Average Shs Out	29.3M	28.9M	29.0M	28.9M	28.8M	28.8M	28.7M	28.6M
Weighted Average Shs Out Dil	30.5M	30.0M	29.8M	29.7M	29.9M	29.9M	29.9M	29.6M